Idinvest portfolio company DAMAE Medical raises €2m to develop its lead product for non-invasive, in-depth imaging and characterization of the skin
DAMAE Medical, a leading French medtech company, announces the closing of a €2 million investment round with Kurma Partners, Idinvest Partners, News Invest, Paris-Saclay Seed Fund co-managed by Partech Ventures, and private investors. DAMAE Medical was founded in September 2014 to revolutionize skin cancer diagnosis through its one-of-a-kind technology based on optical tomography. The company's strong ambition has already paid off: since its inception, over €1 million has been raised from Bpifrance and other sources.

Download the pdf file





One Group, One brand

On April 28, 2021, Idinvest Partners, a wholly-owned subsidiary of Eurazeo since 2020, changed its name to reflect its integral position in the Group.
All activities in the Private Equity, Private Debt and Real Assets businesses now share the single Eurazeo brand.

Find all the information on the Group, its businesses and its commitments on the website.